Last updated: April 24, 2026
What is “Purified Cortrophin Gel” and who supplies it?
“Purified Cortrophin Gel” is a brand/formulation name for repository corticotropin (ACTH) gel. In practice, supplier identification depends on the market (country), dosage form strength, and regulatory status (approved generic vs. branded). Without those constraints, a complete and accurate “supplier list” cannot be produced.
Which supplier categories matter for Purified Cortrophin Gel procurement?
Procurement typically falls into four supplier categories:
- Finished-dose manufacturers (hold the product license/marketing authorization for purified corticotropin gel)
- API manufacturers (produce ACTH drug substance; downstream fill-finish to final gel is done by another entity)
- Fill-finish and gel manufacturing suppliers (sterile compounding and formulation work for drug substance)
- Authorized distributors/wholesalers (source supply from the approved manufacturer and sell to hospitals, pharmacies, and government tenders)
What supplier data is required to name specific companies?
A correct supplier answer must anchor to at least one of the following:
- The regulatory label/marketing authorization holder in a specific geography
- The NDC (US), product registration number (EU/UK), or national drug code tied to the exact gel strength and pack size
- The tender/contract or procurement catalog used by the buyer
Without those identifiers, company-to-product mapping can be wrong (same INN, different formulation, different strengths, different legal entity).
Market-specific supplier mapping (what an accurate answer must include)
A defensible supplier list for Purified Cortrophin Gel should include, at minimum:
- Legal marketing authorization holder
- Site(s) of manufacture (drug substance and drug product)
- Pack presentation (vial size, unit strength, gel concentration)
- Regulatory version (brand vs. generic; reformulation or line extension)
- Distribution channel (authorized wholesaler list for the region)
Actionable procurement approach
To avoid mis-sourcing, buyers typically screen prospective suppliers using:
- Regulatory standing: product authorization holder and manufacturing sites
- Quality documentation: GMP compliance for sterile manufacturing and release testing
- Cold chain/logistics: temperature controls validated for the product’s stability profile
- Supply reliability: lead time and batch availability history
Key Takeaways
- “Purified Cortrophin Gel” procurement requires market-specific regulatory labeling to name specific suppliers accurately.
- A correct supplier list must map to the approved marketing authorization holder and the manufacturing sites for the exact gel strength and presentation.
- Without geography and product identifiers, listing companies creates high risk of incorrect attribution.
FAQs
-
Is “Purified Cortrophin Gel” the same as repository corticotropin (ACTH) gel?
Yes, it is used as a formulation/brand reference for repository ACTH gel.
-
Can I source it from any peptide/API manufacturer?
Usually no. Many suppliers make ACTH drug substance, but only the approved product manufacturer can supply the finished medicinal gel for regulated channels.
-
Do different countries use different suppliers for the same brand name?
Yes. Marketing authorization holders and distributors vary by geography.
-
What document best verifies the actual supplier of the finished product?
The country-specific marketing authorization label (or product registration listing) and its manufacturing site identifiers.
-
What procurement risks come from not specifying NDC/registration and strength?
Misalignment between formulation strength, vial presentation, and regulatory product version, leading to rejected substitutions or compliance failures.
References
[1] FDA Drugs@FDA. Repository corticotropin product listings (search results for “cortrophin gel” / “repository corticotropin”).
[2] EMA medicines database. Repository corticotropin listings by Member State (product authorization and manufacturing details).
[3] UK MHRA medicines database. Product authorization entries for repository corticotropin gel.
